The Marrow Exchange is an underground biobank and organ-sharing cooperative that operates on a principle the corporate healthcare system considers heretical: reciprocity. Members donate biological materials -- blood, tissue samples, bone marrow, genetic profiles -- into a communal pool, and in return gain access to the pool's resources when they need them. No tiered pricing. No insurance algorithms. No Lazarus approval required. If you have contributed, you can draw. The system is crude by corporate standards, the matching algorithms are run on salvaged hardware, and the storage conditions would fail any regulatory inspection -- but for the estimated 60,000 members of the Exchange, it is the difference between having access to biological medicine and having none at all.

The Exchange was founded in 2185 by Yuki Adeyemi-Flores, a hematologist who was fired from a Lazarus blood bank for redistributing expired-but-viable blood products to Shelf clinics instead of incinerating them per corporate disposal protocol. Adeyemi-Flores recognized that the lower tiers of GLMZ contained an enormous untapped biological resource -- millions of healthy bodies producing blood, marrow, and tissue that could save lives if it could be collected, typed, stored, and matched outside corporate control. She built a network of collection points disguised as community health screenings, a storage infrastructure using repurposed industrial refrigeration, and a matching system that runs on the encrypted mesh networks the Shelf's tech community maintains.

The Exchange's most controversial service is its organ waitlist -- a parallel system to Lazarus's official transplant registry that matches donors and recipients based on medical compatibility rather than ability to pay. Members who agree to posthumous organ donation are registered on the waitlist, and the Exchange maintains surgical teams capable of performing transplant operations in field conditions. The success rate is lower than corporate facilities, the complications are higher, and every operation is a legal catastrophe waiting to happen. But the Exchange's waitlist moves -- unlike Lazarus's lower-tier registry, where patients wait an average of eleven years for organs that arrive in three months for Tier 4 subscribers.